These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 17434877)

  • 1. Emergence of a Streptococcus pneumoniae isolate resistant to streptogramins by mutation in ribosomal protein L22 during pristinamycin therapy of pneumococcal pneumonia.
    Cattoir V; Merabet L; Legrand P; Soussy CJ; Leclercq R
    J Antimicrob Chemother; 2007 May; 59(5):1010-2. PubMed ID: 17434877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Macrolide resistance mechanisms among Streptococcus pneumoniae isolated over 6 years of Canadian Respiratory Organism Susceptibility Study (CROSS) (1998 2004).
    Wierzbowski AK; Nichol K; Laing N; Hisanaga T; Nikulin A; Karlowsky JA; Hoban DJ; Zhanel GG
    J Antimicrob Chemother; 2007 Oct; 60(4):733-40. PubMed ID: 17673477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resistance to macrolides by ribosomal mutation in clinical isolates of Turicella otitidis.
    Boumghar-Bourtchai L; Chardon H; Malbruny B; Mezghani S; Leclercq R; Dhalluin A
    Int J Antimicrob Agents; 2009 Sep; 34(3):274-7. PubMed ID: 19414240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phenotypic and molecular characterization of macrolide and streptogramin resistance in Streptococcus mitis from neutropenic patients.
    Achour W; Guenni O; Malbruny B; Canu A; Leclercq R; Hassen AB
    J Antimicrob Chemother; 2004 Jul; 54(1):117-21. PubMed ID: 15190021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diversity of ribosomal mutations conferring resistance to macrolides, clindamycin, streptogramin, and telithromycin in Streptococcus pneumoniae.
    Canu A; Malbruny B; Coquemont M; Davies TA; Appelbaum PC; Leclercq R
    Antimicrob Agents Chemother; 2002 Jan; 46(1):125-31. PubMed ID: 11751122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiology of macrolide and/or lincosamide resistant Streptococcus pneumoniae clinical isolates with ribosomal mutations.
    Doktor SZ; Shortridge VD; Beyer JM; Flamm RK
    Diagn Microbiol Infect Dis; 2004 May; 49(1):47-52. PubMed ID: 15135500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emergence of a 23S rRNA mutation in Mycoplasma hominis associated with a loss of the intrinsic resistance to erythromycin and azithromycin.
    Pereyre S; Renaudin H; Charron A; Bébéar C; Bébéar CM
    J Antimicrob Chemother; 2006 Apr; 57(4):753-6. PubMed ID: 16464889
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-level telithromycin resistance in laboratory-generated mutants of Streptococcus pneumoniae.
    Walsh F; Willcock J; Amyes S
    J Antimicrob Chemother; 2003 Sep; 52(3):345-53. PubMed ID: 12917252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterisation of in vitro-selected mutants of Ureaplasma parvum resistant to macrolides and related antibiotics.
    Pereyre S; Métifiot M; Cazanave C; Renaudin H; Charron A; Bébéar C; Bébéar CM
    Int J Antimicrob Agents; 2007 Feb; 29(2):207-11. PubMed ID: 17196370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unusual resistance patterns in macrolide-resistant Streptococcus pyogenes harbouring erm(A).
    Malhotra-Kumar S; Mazzariol A; Van Heirstraeten L; Lammens C; de Rijk P; Cornaglia G; Goossens H
    J Antimicrob Chemother; 2009 Jan; 63(1):42-6. PubMed ID: 18952616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predominance of 23S rRNA mutants among non-erm, non-mef macrolide-resistant clinical isolates of Streptococcus pneumoniae collected in the United States in 1999-2000.
    Davies TA; Bush K; Sahm D; Evangelista A
    Antimicrob Agents Chemother; 2005 Jul; 49(7):3031-3. PubMed ID: 15980393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Paradoxical High-Level Spiramycin Resistance and Erythromycin Susceptibility due to 23S rRNA Mutation in
    Capitaine A; Woerther PL; Auzou M; Chachaty E; Guérin F; Giard JC; Cattoir V; Isnard C
    Microb Drug Resist; 2020 Jul; 26(7):727-731. PubMed ID: 32031922
    [No Abstract]   [Full Text] [Related]  

  • 13. Macrolide-resistant pneumococcal endocarditis and epidural abscess that develop during erythromycin therapy.
    Butler JC; Lennox JL; McDougal LK; Sutcliffe JA; Tait-Kamradt A; Tenover FC
    Clin Infect Dis; 2003 Jan; 36(2):e19-25. PubMed ID: 12522763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In-vitro susceptibility and molecular characterisation of macrolide resistance mechanisms among Streptococcus pneumonia isolates in The Netherlands: the DUEL 2 study.
    Neeleman C; De Valk JA; Klaassen CH; Meijers S; Mouton JW
    Clin Microbiol Infect; 2005 Apr; 11(4):312-8. PubMed ID: 15760429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Failure of pristinamycin treatment in a case of pneumonia caused by a streptogramins B-type resistant pneumococcus.
    Brevet-Coupe F; Guerin B; Watine J
    Scand J Infect Dis; 1998; 30(4):419-20. PubMed ID: 9817526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of resistance to erythromycin in the genus Rickettsia by mutations in L22 ribosomal protein.
    Rolain JM; Raoult D
    J Antimicrob Chemother; 2005 Aug; 56(2):396-8. PubMed ID: 15996971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ribosomal mutations conferring resistance to macrolides in Streptococcus pneumoniae clinical strains isolated in Germany.
    Reinert RR; Wild A; Appelbaum P; Lütticken R; Cil MY; Al-Lahham A
    Antimicrob Agents Chemother; 2003 Jul; 47(7):2319-22. PubMed ID: 12821488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The first telithromycin-resistant Streptococcus pneumoniae isolate in Japan associated with erm(B) and mutations in 23S rRNA and riboprotein L4.
    Hirakata Y; Mizuta Y; Wada A; Kondoh A; Kurihara S; Izumikawa K; Seki M; Yanagihara K; Miyazaki Y; Tomono K; Kohno S
    Jpn J Infect Dis; 2007 Feb; 60(1):48-50. PubMed ID: 17314426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resistance to quinupristin-dalfopristin due to mutation of L22 ribosomal protein in Staphylococcus aureus.
    Malbruny B; Canu A; Bozdogan B; Fantin B; Zarrouk V; Dutka-Malen S; Feger C; Leclercq R
    Antimicrob Agents Chemother; 2002 Jul; 46(7):2200-7. PubMed ID: 12069975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bacteremic pneumonia due to multidrug-resistant pneumococci in 3 patients treated unsuccessfully with azithromycin and successfully with levofloxacin.
    Fogarty C; Goldschmidt R; Bush K
    Clin Infect Dis; 2000 Aug; 31(2):613-5. PubMed ID: 10987733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.